Comprehensive overview of COVID-19 based on current evidence
- PMID: 32378801
- PMCID: PMC7267400
- DOI: 10.1111/dth.13525
Comprehensive overview of COVID-19 based on current evidence
Abstract
In December 2019, twenty-seven pneumonia patients with unknown causes originated in South China seafood market in Wuhan. The virus infection spread rapidly and swept through China in less than a month. Subsequently, the virus was proven a novel coronavirus and named SARS-CoV-2. The outbreak of novel coronavirus has been determined as a Public Health Emergency of International Concern (PHEIC) by WHO on January 31, 2020. Similar to other coronaviruses like the Middle East Respiratory Syndrome (MERS) CoV and Severe Acute Respiratory Syndrome (SARS) CoV, the novel coronavirus was reported to spread via respiratory droplets and close contact from human to human, which means the virus is highly infectious and dangerous. Unfortunately, till now the virus has spread to over 200 countries/territories/areas around the world and the Coronavirus Disease 2019 (COVID-19) outbreak is continuing to grow. Currently, information sharing and transparency are essential for risk assessment and epidemic control in all endemic areas. In this article, we compared SARS-CoV-2 with SARS-CoV and influenza virus, discussed current researching progress of COVID-19, including clinical characteristics, pathological changes, treatment measures, and so on.
Keywords: COVID-19; SARS-CoV; SARS-CoV-2; influenza virus; pathological changes.
© 2020 Wiley Periodicals LLC.
Conflict of interest statement
The authors disclose no conflict of interest.
Figures




Similar articles
-
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.Pediatr Pulmonol. 2020 Jul;55(7):1584-1591. doi: 10.1002/ppul.24810. Epub 2020 Jun 1. Pediatr Pulmonol. 2020. PMID: 32483934 Free PMC article. Review.
-
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0. Mil Med Res. 2020. PMID: 32169119 Free PMC article. Review.
-
Testing the identification effectiveness of an unknown outbreak of the Infectious Diseases Seeker (IDS) using and comparing the novel coronavirus disease (COVID-19) outbreak with the past SARS and MERS epidemics.J Infect Public Health. 2021 Jan;14(1):123-130. doi: 10.1016/j.jiph.2020.11.014. Epub 2020 Dec 9. J Infect Public Health. 2021. PMID: 33412372 Free PMC article.
-
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4. J Infect Public Health. 2020. PMID: 32778421 Free PMC article.
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
Cited by
-
Influence of public health and infection control interventions during the severe acute respiratory syndrome coronavirus 2 pandemic on the in-hospital epidemiology of pathogens: in hospital versus community circulating pathogens.Antimicrob Resist Infect Control. 2022 Nov 11;11(1):140. doi: 10.1186/s13756-022-01182-z. Antimicrob Resist Infect Control. 2022. PMID: 36369056 Free PMC article.
-
Towards antiviral polymer composites to combat COVID-19 transmission.Nano Sel. 2021 Nov;2(11):2061-2071. doi: 10.1002/nano.202100078. Epub 2021 May 4. Nano Sel. 2021. PMID: 34485980 Free PMC article. Review.
-
Effect of advanced nursing care on psychological disorder in patients with COVID-19: A protocol of systematic review.Medicine (Baltimore). 2020 Jul 2;99(27):e21026. doi: 10.1097/MD.0000000000021026. Medicine (Baltimore). 2020. PMID: 32629726 Free PMC article.
-
An online questionnaire survey on the sexual function of Chinese male adults in the COVID-19 pandemic with loosened controls.Prev Med Rep. 2023 Oct 7;36:102464. doi: 10.1016/j.pmedr.2023.102464. eCollection 2023 Dec. Prev Med Rep. 2023. PMID: 37854665 Free PMC article.
-
Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases.Hum Vaccin Immunother. 2021 Sep 2;17(9):2824-2840. doi: 10.1080/21645515.2021.1908060. Epub 2021 May 11. Hum Vaccin Immunother. 2021. PMID: 33974497 Free PMC article. Review.
References
-
- Wu Y‐C, Chen C‐S, Chan Y‐J. Overview of the 2019 novel coronavirus (2019‐nCoV): the pathogen of severe specific contagious pneumonia (SSCP). J Chin Med Assoc. 2020;83(3):217‐220. - PubMed
-
- National Health Commission of the People's Republic of China . National Health Commission's briefing on the pneumonia epidemic situation. 2020. http://www.nhc.gov.cn/xcs/yqtb/202004/4786774c1fd84e16b29d872f95241561.s.... Accessed April 3, 2020.
-
- World Health Organization . WHO's Coronavirus disease 2019 (COVID‐19) Situation Report–73. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed April 3, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous